Gene · 4921
NIH grants1,545
NIH grants whose papers are about the gene, through NIH's grant-paper links.
661 to 680 of 1,545
Download this page as JSON| Grant | Title | DDR2 papers | Newest fiscal year |
|---|---|---|---|
| R01CA203964 | Highly multiplexed and mutation-sensitive quantitative PCR for cancer diagnostics | 2 | 2020 |
| R01HL070748 | Genetic Analysis of Cardiac Growth | 2 | 2020 |
| R01MH107487 | Cell-specific analysis of sub-kinomes in schizophrenia | 2 | 2020 |
| U54CA193417 | Liver Cancer: pre-Malignant Stiffening, Membrane Transduction, & Nuclear Rheology | 2 | 2020 |
| UM1HG006542 | Baylor Johns Hopkins Center for Mendelian Genetics | 2 | 2020 |
| F30CA203154 | Combination FGFR4 and ER-Targeted Therapy for Invasive Lobular Carcinoma | 1 | 2020 |
| F30CA224970 | Investigating the role of C1-INH in pancreatic ductal adenocarcinoma progression | 1 | 2020 |
| F31CA243293 | ABL kinases promote lung cancer brain metastasis through regulation of transcriptional networks | 1 | 2020 |
| F31ES030982 | Mechanisms of chlorpyrifos-mediated programmed cell death in primary neurons | 1 | 2020 |
| F31LM013056 | Transfer learning approaches for integration of single cell RNA sequencing data from multiple sources | 1 | 2020 |
| F99NS113457 | Identification of Sex Specific Regulatory Drug Targets for Chronic Neuropathic Pain | 1 | 2020 |
| K00CA212456 | New therapeutic opportunities from mining polypharmacology mechanisms of ceritinib in ALK-negative non-small cell lung cancer | 1 | 2020 |
| K07CA201334 | mTOR pathway in breast cancer subtypes by race: A molecular pathological study | 1 | 2020 |
| K99AG062746 | Characterizing the assembly and age-related decline of neural circuits in Drosophila by single-cell profiling | 1 | 2020 |
| K99CA237736 | Non-canonical FADD signaling as a genetic driver of invasive lobular carcinoma | 1 | 2020 |
| OT3HL142479 | The Integration of Trans-omics for Precision Medicine (TOPMED) and Other Heart, Lung, Blood and Sleep (HLBS) Data Sets with the Data Commons | 1 | 2020 |
| OT3HL142481 | The Integration of Trans-omics for Precision Medicine (TOPMED) and Other Heart, Lung, Blood and Sleep (HLBS) Data Sets with the Data Commons | 1 | 2020 |
| P01HD083132 | Gestational Hypoxia and Developmental Plasticity | 1 | 2020 |
| P30AG010133 | Indiana Alzheimer Disease Center | 1 | 2020 |
| P30AG010161 | Rush Alzheimer's Disease Core Center | 1 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/grants?page=34